These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20065049)

  • 21. [YMDD motif variants detected by Inno-Lipa HBV DR assay in chronic hepatitis B patients during lamivudine therapy].
    Arslan U; Ural O; Findik D
    Mikrobiyol Bul; 2008 Jul; 42(3):445-50. PubMed ID: 18822888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance.
    Degertekin B; Hussain M; Tan J; Oberhelman K; Lok AS
    J Hepatol; 2009 Jan; 50(1):42-8. PubMed ID: 19019484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telbivudine, a nucleoside analog inhibitor of HBV polymerase, has a different in vitro cross-resistance profile than the nucleotide analog inhibitors adefovir and tenofovir.
    Seifer M; Patty A; Serra I; Li B; Standring DN
    Antiviral Res; 2009 Feb; 81(2):147-55. PubMed ID: 19028525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of coamplification at lower denaturation temperature-PCR sequencing for early detection of antiviral drug resistance mutations of hepatitis B virus.
    Wong DK; Tsoi O; Huang FY; Seto WK; Fung J; Lai CL; Yuen MF
    J Clin Microbiol; 2014 Sep; 52(9):3209-15. PubMed ID: 24951803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotypic resistance to lamivudine among hepatitis B virus isolates in Mexico.
    Alvarado-Esquivel C; de la Ascensión Carrera-Gracia M; Conde-González CJ; Juárez-Figueroa L; Ruiz-Maya L; Aguilar-Benavides S; Torres-Valenzuela A; Sablon E
    J Antimicrob Chemother; 2006 Feb; 57(2):221-3. PubMed ID: 16373428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy.
    Wongprasit P; Manosuthi W; Kiertiburanakul S; Sungkanuparph S
    AIDS Patient Care STDS; 2010 Apr; 24(4):205-9. PubMed ID: 20377434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of selective real-time PCR for quantitation of lamivudine and adefovir hepatitis B virus-resistant strains and comparison with direct sequencing and line probe assays.
    Lupo J; Larrat S; Hilleret MN; Germi R; Boyer V; Nicod S; Barguès G; Leroy V; Seigneurin JM; Zarski JP; Morand P
    J Virol Methods; 2009 Mar; 156(1-2):52-8. PubMed ID: 19041345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of chronic hepatitis B with primary adefovir resistance].
    Yamazhan T; Sertöz R; Pullukçu H; Taşbakan M; Ulusoy S; Erensoy S
    Mikrobiyol Bul; 2007 Apr; 41(2):297-301. PubMed ID: 17682718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients.
    Lampertico P; Viganò M; Manenti E; Iavarone M; Sablon E; Colombo M
    Gastroenterology; 2007 Nov; 133(5):1445-51. PubMed ID: 17983801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients.
    Yang JX; Liu BM; Li XG; Yan CH; Xu J; Sun XW; Wang YH; Jiao XJ; Yan L; Dong JP; Hou CS; Abuduheilili X; Li T; Zhuang H
    Antivir Ther; 2010; 15(8):1171-8. PubMed ID: 21149924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening and identification of a novel adefovir dipivoxil resistance associated mutation, rtN236V, of HBV from a large cohort of HBV-infected patients.
    Liu Y; Liu W; Li X; Xu Z; Wang X; Li C; Chen L; Xin S; Xu D
    Antivir Ther; 2014; 19(6):551-8. PubMed ID: 24710668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An improved reverse dot hybridization for simple and rapid detection of adefovir dipivoxil-resistant hepatitis B virus.
    Hu Y; Zhang WL; Xie SL; Zhao Y; Hu JL; Cai XF; Lai GQ; Huang AL
    Genet Mol Res; 2012 Jan; 11(1):53-60. PubMed ID: 22290465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus DNA quantitation and detection of core promoter, precore and polymerase mutations in chronic hepatitis B: evaluation and clinical usefulness of three new commercial assays.
    Zampino R; Marrone A; Finnström N; Eriksson T; Törmänen V; Hedrum A; Attanasio V; Rosario P; Utili R; Ruggiero G
    Infez Med; 2005 Jun; 13(2):86-96. PubMed ID: 16220028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents.
    Qi X; Xiong S; Yang H; Miller M; Delaney WE
    Antivir Ther; 2007; 12(3):355-62. PubMed ID: 17591025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of multidrug-resistance mutations of hepatitis B virus (HBV) in a large cohort of chronic HBV-infected patients with treatment of nucleoside/nucleotide analogs.
    Liu Y; Chen R; Liu W; Si L; Li L; Li X; Yao Z; Liao H; Wang J; Li Y; Zhao J; Xu D
    Antiviral Res; 2021 May; 189():105058. PubMed ID: 33711338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Investigation of baseline antiviral resistance in treatment-naive chronic hepatitis B cases].
    Ergünay K; Kahramanoğlu Aksoy E; Simşek H; Alp A; Sener B; Tatar G; Us D; Hasçelik G
    Mikrobiyol Bul; 2013 Oct; 47(4):628-35. PubMed ID: 24237431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large-scale survey of naturally occurring HBV polymerase mutations associated with anti-HBV drug resistance in untreated patients with chronic hepatitis B.
    Mirandola S; Campagnolo D; Bortoletto G; Franceschini L; Marcolongo M; Alberti A
    J Viral Hepat; 2011 Jul; 18(7):e212-6. PubMed ID: 21692935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the INNO-LiPA HBV genotyping assay for determination of hepatitis B virus genotype.
    Osiowy C; Giles E
    J Clin Microbiol; 2003 Dec; 41(12):5473-7. PubMed ID: 14662927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus.
    Beck IA; Payant R; Ngo-Giang-Huong N; Khamduang W; Laomanit L; Jourdain G; Frenkel LM
    J Virol Methods; 2016 Jul; 233():51-5. PubMed ID: 27025356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.